**Question:** Which of the following statements about Von-Hippel Lindau syndrome is true:

A. It is a rare genetic disorder characterized by the development of multiple tumors in various organs.
B. It is a condition affecting only the eyes and vision.
C. It is a condition caused by mutations in the VHL gene.
D. It is a condition caused by mutations in the CTNNB1 gene.

**Correct Answer:** D. Von-Hippel Lindau syndrome is a rare genetic disorder characterized by the development of multiple tumors in various organs. It is caused by mutations in the CTNNB1 gene, which encodes beta-catenin protein. This protein plays a crucial role in cell growth, differentiation, and apoptosis, and its dysfunction leads to uncontrolled cell growth and tumor formation.

**Why the Correct Answer is Right:**

Von-Hippel Lindau syndrome is indeed a rare genetic disorder, as mentioned in option D. The syndrome is characterized by the development of multiple tumors in various organs, including the kidneys, adrenal glands, brain, pancreas, and retina. This is due to mutations in the CTNNB1 gene, which encodes the beta-catenin protein.

**Why Option A is Incorrect:**

Option A is incorrect because Von-Hippel Lindau syndrome is not limited to the eyes and vision but affects multiple organs. Mutation in the CTNNB1 gene is responsible for this syndrome, but it is not specific to the eyes and vision.

**Why Option C is Incorrect:**

Option C is incorrect because Von-Hippel Lindau syndrome is caused by mutations in the CTNNB1 gene, not the VHL gene as stated in this option. The VHL gene is associated with hemangioblastomas, which are not a part of Von-Hippel Lindau syndrome.

**Why Option D is Correct:**

Option D is correct because Von-Hippel Lindau syndrome is caused by mutations in the CTNNB1 gene, which encodes the beta-catenin protein. This protein plays a crucial role in cell growth, differentiation, and apoptosis. The dysfunction of beta-catenin protein leads to uncontrolled cell growth and tumor formation. This is a key mechanism behind the development of tumors in various organs in patients with Von-Hippel Lindau syndrome.

**Clinical Pearls:**

1. The CTNNB1 gene mutation is associated with the development of multiple tumors in various organs.
2. The beta-catenin protein plays a vital role in the regulation of cell growth, differentiation, and apoptosis, and its dysfunction leads to uncontrolled cell growth and tumor formation.
3. Early diagnosis and surveillance are crucial for early detection and management of tumors in patients with Von-Hippel Lindau syndrome.

4. The VHL gene is associated with hemangioblastomas, which are not a part of Von-Hippel Lindau syndrome.